This week, the U.S. House and Senate are back in action after the Memorial Day break. The Senate is gearing up for some serious behind-the-scenes work on the budget reconciliation bill. On the other side, the House Committee on Appropriations is about to kick off discussions on bills that will steer funding for the federal government, starting with markups on June 5, 2025. This includes military and agricultural funding. While these bills may not end up as the final version President Trump will sign, they give a sneak peek into his budget strategies.
Additionally, the House is set to vote on H.R. 2483, aimed at bolstering treatment and mental health services for substance use disorders.
Hearings This Week
Several important hearings are on the calendar:
- The Senate Committee on HELP holds a hearing on the Over-the-Counter Monograph Drug User Fee Program on June 4, 2025, at 10 a.m.
- The House Committee on Science, Space and Technology hosts a joint hearing on biotechnology priorities on June 5, 2025, at 10 a.m.
- The House Committee on Education and the Workforce discusses the Department of Labor’s priorities on June 5, 2025, at 10:15 a.m.
- The Senate Committee on Appropriations meets for a budgeting hearing on the Indian Health Service on June 5, 2025, at 1:30 p.m.
Week in Review
The House and Senate were in recess from May 26-30, 2025, in observance of Memorial Day.
Administrative Updates
Executive Order Updates
The Trump Administration has been churning out various executive orders. Notably, an EO titled “Restoring Gold Standard Science” aims to revamp scientific integrity in federal research. It focuses on ensuring transparency and validity in federally funded studies, likely paving the way for varied perspectives in federal processes.
Budget Request Highlights
HHS has released its proposed FY 2026 budget, highlighting cuts and restructuring initiatives, including a $31 billion reduction from FY 2025 levels. The NIH faces significant budget decreases, and structural changes across HHS could suggest shifts in strategic priorities.
Holland and Knight Launches Health AI Navigator
To keep healthcare professionals and innovators updated on the shifting landscape around AI in the industry, Holland & Knight introduced the Health AI Navigator, an online tool designed to track and clarify AI-related policies.
Legislative Updates
Senator Bernie Sanders has introduced a bill aimed at lowering prescription drug prices, responding to concerns over U.S. drug costs compared to those in other countries.
The House Committee on Appropriations is getting ready to mark up bills for FY 2026, starting with military and agricultural funding.
Regulatory Updates
The CMS is increasing audits of Medicare Advantage plans and implementing oversight to ensure federal funds aren’t improperly used for healthcare services to immigrants without satisfactory status. Meanwhile, the FDA is streamlining drug importation regulations from Canada.
Why should I read this?
If you’re keeping an eye on U.S. healthcare policies or regulations, this is essential reading. With changes and proposals that could shape the future of health services and regulations—especially around AI and drug pricing—this summary highlights the key points to ensure you’re in-the-know without having to sift through all the details. It’s a real time-saver!